Ratings Convergenze S.p.A. Società Benefit

Equities

CVG

IT0005426215

Market Closed - Borsa Italiana 16:44:59 05/07/2024 BST 5-day change 1st Jan Change
1.87 EUR 0.00% Intraday chart for Convergenze S.p.A. Società Benefit +2.19% +35.51%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Multiline Utilities

1st Jan change Capi. Investor Rating ESG Refinitiv
+35.51% 15.18M -
-17.43% 88.46B
C+
+42.31% 70.33B
C
-.--% 51.55B -
B+
+1.87% 48.18B
B+
-10.23% 37.46B
C+
+21.13% 36.89B
B+
+1.69% 34.93B
B-
-18.41% 27.06B
C
+3.22% 22.85B
B-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CVG Stock
  4. Ratings Convergenze S.p.A. Società Benefit